Paper18958751
Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
Brodsky RA and 1 other. Autoimmunity, 2008. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. Papers, record 18958751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18958751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Cyclophosphamide | Major topic |
| Immunosuppressive Agents | Major topic |
| Dose-Response Relationship, Immunologic | |
| Humans | |
| Stem Cell Transplantation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA015396 | NCI NIH HHS | United States | P01CA015396 | PubMed and NIH |
Source NIH RePORTER
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8555470 | Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. | Blood | 1996 | https://conductscience.org/library/papers/8555470 | PubMed |
| 2 | 15090586 | High dose cyclophosphamide for severe refractory myasthenia gravis. | J Neurol Neurosurg Psychiatry | 2004 | https://conductscience.org/library/papers/15090586 | PubMed |
| 3 | 773651 | Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. | Exp Hematol | 1976 | https://conductscience.org/library/papers/773651 | PubMed |
| 4 | 17252566 | Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide. | Pediatr Blood Cancer | 2007 | https://conductscience.org/library/papers/17252566 | PubMed |
| 5 | 11100024 | Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. | J Am Acad Dermatol | 2000 | https://conductscience.org/library/papers/11100024 | PubMed |
| 6 | 7742535 | Assessment of aldehyde dehydrogenase in viable cells. | Blood | 1995 | https://conductscience.org/library/papers/7742535 | PubMed |
| 7 | 6488175 | Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. | Cancer Res | 1984 | https://conductscience.org/library/papers/6488175 | PubMed |
| 8 | 11114821 | Treatment of severe aplastic anemia using high-dose cyclophosphamide alone in China. | Haematologica | 2000 | https://conductscience.org/library/papers/11114821 | PubMed |
| 9 | 15885298 | Aplastic anaemia. | Lancet | 2005 | https://conductscience.org/library/papers/15885298 | PubMed |
| 10 | 12084892 | High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. | Neurology | 2002 | https://conductscience.org/library/papers/12084892 | PubMed |
| 11 | 17133541 | Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/17133541 | PubMed |
| 12 | 15765114 | Autologous hematopoietic stem cell transplantation for autoimmune diseases. | Bone Marrow Transplant | 2005 | https://conductscience.org/library/papers/15765114 | PubMed |
| 13 | 4109931 | Aplastic anaemia treated by marrow transplantation. | Lancet | 1972 | https://conductscience.org/library/papers/4109931 | PubMed |
| 14 | 12195780 | High-dose cyclophosphamide for severe systemic lupus erythematosus. | Lupus | 2002 | https://conductscience.org/library/papers/12195780 | PubMed |
| 15 | 319010 | Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies. | Exp Hematol | 1977 | https://conductscience.org/library/papers/319010 | PubMed |
| 16 | 9867758 | Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. | Ann Intern Med | 1998 | https://conductscience.org/library/papers/9867758 | PubMed |
| 17 | 11426504 | High-dose cyclophosphamide in the treatment of severe aplastic anemia in children. | Am J Hematol | 2001 | https://conductscience.org/library/papers/11426504 | PubMed |
| 18 | 12717089 | Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. | J Pediatr Gastroenterol Nutr | 2003 | https://conductscience.org/library/papers/12717089 | PubMed |
| 19 | 12528116 | High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. | Arthritis Rheum | 2003 | https://conductscience.org/library/papers/12528116 | PubMed |
| 20 | 11306068 | Genetic dissection of retinoid dehydrogenases. | Chem Biol Interact | 2001 | https://conductscience.org/library/papers/11306068 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39576169 | High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review. | Eur J Rheumatol | 2024 | https://conductscience.org/library/papers/39576169 | PubMed |
| 27313069 | Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide. | Pediatrics | 2016 | https://conductscience.org/library/papers/27313069 | PubMed |
| 22969816 | Hematopoietic stem cell transplantation for systemic lupus erythematosus. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22969816 | PubMed |
| 21304001 | Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21304001 | PubMed |
| 21295330 | High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease. | Semin Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21295330 | PubMed |
| 20727534 | Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome. | J Pediatr | 2011 | https://conductscience.org/library/papers/20727534 | PubMed |
| 20581881 | Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. | Bone Marrow Transplant | 2011 | https://conductscience.org/library/papers/20581881 | PubMed |
| 20087683 | High-dose cyclophosphamide for autoimmunity and alloimmunity. | Immunol Res | 2010 | https://conductscience.org/library/papers/20087683 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKR1A1 | 10327 | PubTator's text mining | https://conductscience.org/library/genes/10327 | NCBI Gene |
| ALDH1A1 | 216 | PubTator's text mining | https://conductscience.org/library/genes/216 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18958751
GET https://conductscience.org/api/papers/v1/18958751/references?page=2